AI VIVO is a Cambridge based systems pharmacology company which specialises in a powerful phenotypic approach to drug discovery that still works when little is known about disease specific targets.

They developed an AI driven phenotypic model for COVID-19. Interestingly this highlighted several drugs which have previously been identified as potential treatments for the virus, as well as a number of other drugs that have been approved for other indications, as well as some combination proposals which could increase the effectiveness.

In addition other compounds have been identified that could be helpful to treat the disease.

Fantastic work by Peyman Gifani and the team. Congratulations.

It will be really interesting to see the results when these drugs and combination get tested. If you can help with the testing of these potential COVID treatments, please contact AI VIVO

For more information, please see –